A study by researchers from the University of Liège and Rockefeller University has uncovered the detailed structure and function of a molecular machine critical to the survival of trypanosomatid parasites. These parasites cause serious diseases in humans, animals, and plants, including leishmaniasis, sleeping sickness, and Chagas disease in humans. The findings, published in Nature Communications, reveal a biological mechanism that has puzzled scientists for nearly 40 years. The research highlights unique features of these organisms and may lead to the development of more effective treatments. Trypanosomatids rely on a special form of RNA processing known as Spliced Leader (SL) RNA trans-splicing. Unlike most organisms, where RNA splicing is done internally, these parasites depend on this external process. Almost all of their messenger RNAs receive a short RNA sequence at the beginning, which is essential for their cells to function properly. This mechanism is vital for the parasite's survival, and importantly, it does not exist in humans. This makes it a promising target for new drugs that can kill the parasites without harming human cells. The molecular machine responsible for this process, called the trans-spliceosome, is a complex structure that scientists have known about for decades but have struggled to understand in detail. To study it, researchers used cryogenic electron microscopy (cryo-EM), a technique that involves rapidly freezing molecules and capturing images of them. Using this method, they were able to observe two key stages of the machine's activity. These images show how the SL RNA attaches to messenger RNA and how the structure changes afterward, revealing the precise arrangement of the machine's components and the roles of unique proteins found only in trypanosomatids. While the trans-spliceosome shares some similarities with the splicing machinery in human cells, it has evolved significantly to perform its unique function. This discovery provides insight into how such molecular machines have adapted over time and may help scientists understand the broader evolutionary history of these processes in eukaryotic organisms. By revealing the detailed structure of the trans-spliceosome, the study offers a foundation for creating drugs that can specifically target this machinery in parasites, potentially leading to more effective and less harmful treatments for the diseases they cause.